Description
BSE announces revised settlement dates for the takeover offer acquisition window for PHARMAIDS PHARMACEUTICALS LIMITED conducted from August 4-18, 2025.
Summary
BSE has issued a revised settlement schedule for the takeover offer acquisition window for PHARMAIDS PHARMACEUTICALS LIMITED. The takeover bid period ran from August 4-18, 2025, with updated obligation download and settlement dates.
Key Points
- Settlement Type: Takeover (Settlement No. 2025067)
- Bid Period: August 4, 2025 to August 18, 2025
- Revised Obligation Download Date: August 22, 2025
- Revised Settlement Date: August 25, 2025
- Demat shares must be delivered through Early Pay-in mechanism only
- Market Type “Takeover” and settlement No. 2025035 to be used in depository system
Regulatory Changes
This notice revises the previously announced settlement calendar from Notice No. 20250801-27, updating the obligation download and final settlement dates for the takeover process.
Compliance Requirements
- Members/Custodians must use Early Pay-in of Shares mechanism for demat share delivery
- Must specify Market Type “Takeover” and settlement No. 2025035 in depository system
- Refer to MBRSTD_OTB_CM_mmm_SettNo file for client-wise stamp duty charges
- Follow revised guidelines for acquisition of shares through stock exchange (Notice No. 20200528-32)
Important Dates
- Bid Start Date: August 4, 2025
- Bid End Date: August 18, 2025
- Revised Obligation Download: August 22, 2025
- Revised Settlement Date: August 25, 2025
Impact Assessment
This revision affects the settlement timeline for the PHARMAIDS takeover, requiring market participants to adjust their settlement processes and ensure compliance with the new dates. The change primarily impacts members and custodians involved in the takeover settlement process.
Impact Justification
Affects specific takeover settlement with revised dates that market participants must follow